NYSE:MED - Medifast Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $133.34 -0.57 (-0.43 %) (As of 12/16/2018 07:17 AM ET)Previous Close$133.34Today's Range$130.01 - $137.8852-Week Range$61.96 - $260.98Volume289,484 shsAverage Volume253,683 shsMarket Capitalization$1.60 billionP/E Ratio58.23Dividend Yield1.44%Beta0.42 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing. As of December 31, 2017, it operated 16 franchised Medifast weight control centers in Arizona, California, Louisiana, Minnesota, and Wisconsin; and 18 reseller locations in California, Maryland, and Pennsylvania. The company was founded in 1980 and is headquartered in Baltimore, Maryland. Receive MED News and Ratings via Email Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Miscellaneous food preparations & kindred products Sub-IndustryPersonal Products SectorConsumer Staples Current SymbolNYSE:MED Previous Symbol CUSIP58470H10 Webwww.medifast1.com Phone410-581-8042 Debt Debt-to-Equity RatioN/A Current Ratio2.42 Quick Ratio1.72 Price-To-Earnings Trailing P/E Ratio58.23 Forward P/E Ratio29.63 P/E Growth1.48 Sales & Book Value Annual Sales$301.56 million Price / Sales5.29 Cash Flow$2.7346 per share Price / Cash Flow48.76 Book Value$9.10 per share Price / Book14.65 Profitability EPS (Most Recent Fiscal Year)$2.29 Net Income$27.72 million Net Margins10.95% Return on Equity43.45% Return on Assets30.19% Miscellaneous Employees399 Outstanding Shares11,970,000Market Cap$1.60 billion OptionableOptionable Medifast (NYSE:MED) Frequently Asked Questions What is Medifast's stock symbol? Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED." How often does Medifast pay dividends? What is the dividend yield for Medifast? Medifast declared a quarterly dividend on Wednesday, December 12th. Stockholders of record on Friday, December 21st will be paid a dividend of $0.75 per share on Thursday, February 7th. This represents a $3.00 annualized dividend and a dividend yield of 2.25%. The ex-dividend date is Thursday, December 20th. This is an increase from Medifast's previous quarterly dividend of $0.48. View Medifast's Dividend History. How were Medifast's earnings last quarter? Medifast Inc (NYSE:MED) issued its quarterly earnings data on Tuesday, November, 6th. The specialty retailer reported $1.14 earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of $1.14. The specialty retailer had revenue of $139.20 million for the quarter, compared to analyst estimates of $125.20 million. Medifast had a net margin of 10.95% and a return on equity of 43.45%. The firm's revenue for the quarter was up 80.3% compared to the same quarter last year. During the same period last year, the firm posted $0.55 earnings per share. View Medifast's Earnings History. When is Medifast's next earnings date? Medifast is scheduled to release their next quarterly earnings announcement on Tuesday, March 5th 2019. View Earnings Estimates for Medifast. What guidance has Medifast issued on next quarter's earnings? Medifast issued an update on its FY18 earnings guidance on Tuesday, November, 6th. The company provided earnings per share (EPS) guidance of $4.45-4.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.47. The company issued revenue guidance of $492.5-497.5 million, compared to the consensus revenue estimate of $470.31 million.Medifast also updated its FY 2018 guidance to $4.45-4.50 EPS. What price target have analysts set for MED? 2 brokers have issued 1 year price objectives for Medifast's shares. Their predictions range from $249.00 to $249.00. On average, they anticipate Medifast's stock price to reach $249.00 in the next year. This suggests a possible upside of 86.7% from the stock's current price. View Analyst Price Targets for Medifast. What is the consensus analysts' recommendation for Medifast? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medifast. Has Medifast been receiving favorable news coverage? News coverage about MED stock has been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Medifast earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned headlines about the specialty retailer a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term. Who are some of Medifast's key competitors? Some companies that are related to Medifast include MCCORMICK & CO /SH (MKC), WANT WANT CHINA/ADR (WWNTY), Greencore Group (GNCGY), Farmer Bros (FARM), China Marine Food Group (CMFO) and Jammin Java (JAMN). Who are Medifast's key executives? Medifast's management team includes the folowing people: Mr. Daniel R. Chard, CEO & Director (Age 53)Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 56)Mr. Bill Baker, Exec. VP of Information Technology (Age 46)Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 47)Mr. Joseph Kelleman, VP of Fin. & Corp. Controller (Age 63) Who are Medifast's major shareholders? Medifast's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.16%), Vanguard Group Inc. (10.74%), Vanguard Group Inc (10.74%), Renaissance Technologies LLC (8.01%), Dimensional Fund Advisors LP (5.73%) and Acadian Asset Management LLC (3.57%). Company insiders that own Medifast stock include Charles P Connolly, Constance J Hallquist, Daniel R Chard, Glenn W Welling, Jeremy John Martin, Michael A Hoer, Michael C Macdonald, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast. Which major investors are selling Medifast stock? MED stock was sold by a variety of institutional investors in the last quarter, including Teachers Advisors LLC, Man Group plc, TIAA CREF Investment Management LLC, Renaissance Technologies LLC, Acadian Asset Management LLC, Wells Fargo & Company MN, O Shaughnessy Asset Management LLC and Seizert Capital Partners LLC. Company insiders that have sold Medifast company stock in the last year include Charles P Connolly, Constance J Hallquist and Michael C Macdonald. View Insider Buying and Selling for Medifast. Which major investors are buying Medifast stock? MED stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc, Vanguard Group Inc., BlackRock Inc., AQR Capital Management LLC, Robeco Institutional Asset Management B.V., Robeco Institutional Asset Management B.V., SG Americas Securities LLC and Connor Clark & Lunn Investment Management Ltd.. Company insiders that have bought Medifast stock in the last two years include Daniel R Chard, Glenn W Welling, Michael A Hoer and Simon TP Ridgway. View Insider Buying and Selling for Medifast. How do I buy shares of Medifast? Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Medifast's stock price today? One share of MED stock can currently be purchased for approximately $133.34. How big of a company is Medifast? Medifast has a market capitalization of $1.60 billion and generates $301.56 million in revenue each year. The specialty retailer earns $27.72 million in net income (profit) each year or $2.29 on an earnings per share basis. Medifast employs 399 workers across the globe. What is Medifast's official website? The official website for Medifast is http://www.medifast1.com. How can I contact Medifast? Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected] MarketBeat Community Rating for Medifast (NYSE MED)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 247 (Vote Outperform)Underperform Votes: 266 (Vote Underperform)Total Votes: 513MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/16/2018 by MarketBeat.com StaffFeatured Article: What is Cost of Capital?